Yıl: 2020 Cilt: 31 Sayı: 9 Sayfa Aralığı: 658 - 666 Metin Dili: İngilizce DOI: 10.5152/tjg.2020.19169 İndeks Tarihi: 05-05-2021

Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan

Öz:
Background/Aims: This study gives a clue about genotypes, subgenotypes, and subtypes of hepatitis B (HBV), Hepatitis C (HCV), and Hepatitis D (HDV) viruses in general population of Afghanistan. Materials and Methods: A total of 234 Hepatitis B surface antigen (HBsAg), 44 anti-HCV, and 5 antidelta positive patients from 25–70- age group were studied through a rapid screening test among 5898 residents of Afghanistan. After quantifying viral load, genotypingof 61 HBV, 29 HCV, and 1 HDV samples were accomplished by sequencing of a segment of the HBV Pre S, HCV NS5B, and HDV Delta antigen regions, respectively. Clinically important variants of the HBV polymerase gene, the “a” determinant of HBsAg, HCV NS5B, and NS3 regions were assessed.Results: All HBV isolates were dispersed throughout the genotype D branch and ayw2 was the only subtypes found. The anti-HDV prevalence among HBsAg-positive individuals was 2.2% and the single HDV sample, from HDV genotype I. Analysis of HCV isolates revealed subtype HCV genotype 1b (HCV-1b) in 75.86%, HCV-3a in 20.69%, and HCV-3b in 3.44% patients. The observed mutant variants in the major hydrophilic region (MHR) of HBsAg were Y100 15%, Q101 5%, G102 15%, T115 45%, P120 5%, and T131 5%. Likewise, S213T 10%, Q215P 5%, and N248H 100% mutations were detected in the HBV polymerase region. C316N mutation was prevalent in 72.7% of HCV-1b participants.Conclusion: Genotypic variation in Afghan patients is in line with the ones existing in neighboring countries and regions. HBV genotypes D1, subtype ayw2, HDV RNA type I, and HCV RNA genotype 1b are likely to be dominant in Afghan patients
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Riaz M, Idrees M, Kanwal H, Kabir F. An overview of triple infection with hepatitis B, C and D viruses. Virol J 2011; 8: 368. [Crossref]
  • 2. Berger S. Infectious disease of Afghanistan. Gideon e-book series. 2018 edition. GIDEON Informatics, Inc, Los Angeles, California, USA. 2018; 91-96, ISBN 978-1-4988-1702-8.
  • 3. Blach S, Zeuzem S, Manns M, et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017; 2: 161-76. [Crossref]
  • 4. Islam Saeed KM. Burden of hepatitis B, hepatitis C and HIV infections among adult citizens in Kandahar city, Afghanistan. OSR J Pharm 2017; 7: 78-85. [Crossref]
  • 5. Islam Saeed KM. Descriptive study of hepatitis B, C and HIV infections and associated factors among adult population in Kabul city, 2015. OSR J Pharm 2017; 7: 69-77. [Crossref]
  • 6. Islam Saeed KM. Prevalence and associated factors of hepatitis B, hepatitis C and HIV infection in Jalalabad city, Afghanistan. GMJ 2016; 1: 62-74.
  • 7. Islam Saeed KM. Prevalence and associated factors of Hepatitis B, Hepatitis C and HIV infections among adult citizens in Mazar-e-Sharif city, Afghanistan. OSR J Pharm 2016; 6: 61-72.
  • 8. Jacobson IM, Dienstag JL, Werner BG, Brettler DB, Levine PH, Mushahwar IK. Epidemiology and clinical impact of hepatitis D virus (delta) infection. Hepatology 1985; 5: 188-91. [Crossref]
  • 9. Huang Y, Lok AS. Viral factors and outcomes of chronic HBV infection. Am Gastroenterol 2011; 106: 93-5. [Crossref]
  • 10. Yurdaydin C, Idilman R, Bozkaya H, Bozdayi AM. Natural history and treatment of chronic delta hepatitis. J Viral Hepat 2010; 17: 749-56. [Crossref]
  • 11. Bozdayi AM, Aslan N, Bozdayi G, et al. Molecular epidemiology of hepatitis B, C and D viruses in Turkish patients. Arch Virol 2004; 149: 2115-29. [Crossref]
  • 12. Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000; 13: 223-35. [Crossref]
  • 13. Bukh J, Purcell RH, Miller RH. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 1994; 91: 8239-43. [Crossref]
  • 14. Robertson B, Myers G, Howard C, et al. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. Arch Virol 1998; 143: 2493-503. [Crossref]
  • 15. Stuyver L, Arnhem W, Wyseur A, Hernandez F, Delaporte E, Maertens G. Classification of hepatitis C viruses based on phylogenetic analysis of envelope 1 and nonstructural 5b regions and identification of five additional subtypes. Proc Natl Acad Sci USA 1994; 91: 10134-8. [Crossref]
  • 16. Pascarella S and Negro F. HepatitisD virus: an update. Liver Int 2011; 31: 7-21. [Crossref]
  • 17. Wu JC, Huang IA, Huang YH, Chen JY, Sheen IJ. Mixed genotypes infection with hepatitis D virus. J Med Virol 1999; 57: 64-7.
  • 18. Sagnelli E, Alessio L, Sagnelli C, et al. Hepatitis B virus genotypes, epidemiological characteristics, and clinical presentation of HBV chronic infection in immigrant populations living in southern Italy. Hepat Mon 2017; 17: 1-8. [Crossref]
  • 19. Guirgis BSS, Abbas RO, Azzazy HME. Hepatitis B virus genotyping: current methods and clinical implications. Int J Infect Dis 2010; 14: 941-53. [Crossref]
  • 20. Heidrich B, Serrano BC, Idilman R, et al. HBeAg-positive hepatitis delta: Virological patterns and clinical long-term outcome. Liver International 2012; 32: 1415-25. [Crossref]
  • 21. Opaleye OO, Japhet OM, Adewumi OM, et al. Molecular epidemiology of hepatitis D virus circulating in Southwestern Nigeria. Virol J 2016; 13: 61. [Crossref]
  • 22. Benvegnu L, Pontisso P, Cavalletto D, Noventa F, Chemello L, Alberti A. Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis. Hepatology 1997; 25: 211-15. [Crossref]
  • 23. Bruno S, Silini E, Crsignani A, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a prospective study. Hepatology 1997; 25: 754-58. [Crossref]
  • 24. Hatzakis A, Katsoulidou A, Kaklamani E, et al. Hepatitis C virus 1b is the dominant genotype in HCV related carcinogenesis: a case-control study. Int J Cancer 1996; 68: 51-3.
  • 25. Martinot-Peignoux M, Marcellin P, Pouteau M, et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995; 22: 1050-6. [Crossref]
  • 26. Pozzato G, Kaneko S, Moretti M, et al. Different genotypes of hepatitis C virus are associated with different severity of chronic liver disease. J Med Virol 1994; 43: 291-6. [Crossref]
  • 27. Silini E, Botelli R, Asti M, et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis, a case-control study. Gastroenterology 1996; 111: 199-205. [Crossref]
  • 28. Yotsuyanagi H, Kolke K, Yasuda K, et al. Hepatitis C virus genotypes and hepatocellular carcinoma. Cancer 1995; 76: 1352-5.
  • 29. Karatayli E, Altunoğlu YT, Karatayli SC, et al. A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control. J Clin Virol 2014; 60: 11-5. [Crossref]
  • 30. Bozdayi G, Türkyilmaz AR, Idilman R, et al. Complete genome sequence and phylogenetic analysis of hepatitis B virus isolated from Turkish patients with chronic HBV infection. J Med Virol 2005; 76: 476-81. [Crossref]
  • 31. Alagöz GK, Karatayli SC, Karatayli E, et al. Hepatitis C virus genotype distribution in Turkey remains unchanged after a decade: Performance of phylogenetic analysis of the NS5B, E1, and 5UTR regions in genotyping efficiency. Turk J Gastroenterol 2014; 25: 405-10. [Crossref]
  • 32. Celik I, Karatayli E, Cevik E, et al. Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patients. Arch Virol 2011; 156: 2215-20. [Crossref]
  • 33. Danielsson A, Palanisamy N, Golbob S, et al. Transmission of hepatitis C virus among intravenous drug users in the Uppsala region of Sweden. Infect Ecol Epidemiol 2014; 15: 4. [Crossref]
  • 34. Colson P, Brouk N, Lembo F, Castellani P, Tamalet C, Gérolami R. Natural presence of substitution R155K within hepatitis C virus NS3 protease from a treatment-naïve chronically infected patient. Hepatology 2008; 47: 766-7. [Crossref]
  • 35. Kumar S, Stecher G, Tamura K. MEGA7: Molecular evolutionary genetics analysis version 7.0 for bigger datasets. Mol Biol Evol 2016; 33: 1870-4. [Crossref]
  • 36. The Hepatitis B Virus Database genotyping tool. Available online: https://hbvdb.ibcp.fr/HBVdb/HBVdbGenotype
  • 37. Genafor−Open Services for Medical Research. Available online: http://hcv.geno2pheno.org/ index.php
  • 38. VassarStats: Website for Statistical Computation. Available online: http://vassarstats.net/
  • 39. Khan S and Attaullah S. Share of Afghanistan populace in hepatitis B and hepatitis C infection’s pool: is it worthwhile? Virol J 2011; 8: 216. [Crossref]
  • 40. Amini-Bavil-Olyaee S, Alavian SM, Adeli A, et al. Hepatitis B virus genotyping, Core promoter, and PreCore/Core mutations among Afghan patients infected with hepatitis B: A preliminary report. J Med Virol 2006; 78: 358-64. [Crossref]
  • 41. Attaullah S, Rehman S, Khan S, Ali I, Ali S, Niaz Khan S. Prevalence of hepatitis B virus genotypes in HBsAg positive individuals of Afghanistan. Virol J 2011; 8: 281. [Crossref]
  • 42. Kramvis A, Kew M, François G. Hepatitis B virus genotypes. Vaccine 2005; 23: 2409-23. [Crossref]
  • 43. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect 2008; 14: 858-66. [Crossref]
  • 44. Haghshenas MR, Arabi M, Mousavi T. Hepatitis B genotypes in Iran. Mater Sociomed 2014; 26: 129-33. [Crossref]
  • 45. Mahmood M, Anwar MA, Khanum A, Zaman N, Raza A. Distribution and clinical significance of hepatitis B virus genotypes in Pakistan. BMC Gastroenterology 2016; 16: 104. [Crossref]
  • 46. Croagh CM, Desmond PV, Bell SJ. Genotypes and viral variants in chronic hepatitis B: A review of epidemiology and clinical relevance. World J Hepatol 2015; 7: 289-303. [Crossref]
  • 47. Lampertico P, Maini M, Papatheodoridis G. Optimal management of hepatitis B virus infection - EASL Special Conference. J Hepatol 2015; 63: 1238-53. [Crossref]
  • 48. Sanders-Buell E, Rutvisuttinunt W, Todd CS, et al. Hepatitis C genotype distribution and homology among geographically disparate injecting drug users in Afghanistan. J Med Virol 2013; 85: 1170-9. [Crossref]
  • 49. Üçbilek E, Abaylı B, Koyuncu MB, et al. Distribution of hepatitis C virus genotypes among intravenous drug users in the Çukurova region of Turkey. Turk J Med Sci 2016; 46: 66-71. [Crossref]
  • 50. Khodabandehloo M, Roshani D. Prevalence of hepatitis C virus genotypes in Iranian patients: A systematic review and meta-analysis. Hepat Mon 2014; 14: e22915. [Crossref]
  • 51. Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon 2013; 13: e7991. [Crossref]
  • 52. Taherkhani R, Farshadpour F. Epidemiology of hepatitis C virus in Iran. World J Gastroenterol 2015; 21: 10790-810. [Crossref]
  • 53. Attaullah S, Khan S, Ali I. Hepatitis C virus genotypes in Pakistan: a systemic review. Virol J 2011; 8: 433. [Crossref]
  • 54. Petruzziello A, Marigliano S, Loquercio G, Cozzolino A, Cacciapuoti C. Global epidemiology of hepatitis C virus infection: an up-date of the distribution and circulation of hepatitis C virus genotypes. World J Gastroenterol 2016; 22: 7824-40. [Crossref]
  • 55. Gower E, Estes C, Blach S, Razavi-Shearer K, Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol 2014; 61: 45-57. [Crossref]
  • 56. Lee CM, Hung CH, Lu SN, Changchien CS. Hepatitis C virus genotypes: Clinical relevance and therapeutic implications. Chang Gung Med J 2008; 31: 16-25.
  • 57. Bozdayi AM, Bozkaya H, Türkyilmaz AR, et al. Nucleotide divergences in the core promoter and precore region of genotype D hepatitis B virus in patients with persistently elevated or normal ALT levels. J Clin Virol 2001; 21: 91-101. [Crossref]
  • 58. Idilman R, Cinar K, Seven G, et al. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients. J Viral Hepat 2012; 19: 220-6. [Crossref]
  • 59. Caligiuri P, Cerruti R, Icardi G, Bruzzone B. Overview of hepatitis B virus mutations and their implications in the management of infection. World J Gastroenterol 2016; 22: 145-54. [Crossref]
  • 60. Amini-Bavil-Olyaee S, Vucur M, Luedde T, Trautwein C, Tacke F. Differential impact of immune escape mutations G145R and P120T on the replication of lamivudine-resistant hepatitis B virus e antigen-positive and -negative strains. J Virol 2010; 84: 1026-33. [Crossref]
  • 61. Coppola N, Onorato L, Minichini C, et al. Clinical significance of hepatitis B surface antigen mutants. World J Hepatol 2015; 7: 2729-39. [Crossref]
  • 62. Jammeh S, Thomas HC, Karayiannis P. Replicative Competence of the T131I, K141E, and G145R Surface Variants of Hepatitis B Virus. J Infect Dis 2007; 196: 1010-3. [Crossref]
  • 63. Amini-Bavil-Olyaee S, Herbers U, Mohebbi SR, et al. Prevalence, viral replication efficiency and drug sensitivity towards Adefovir of Q215 polymerase mutations in the hepatitis B virus genome. J Hepatol 2009; 51: 647-54. [Crossref]
  • 64. Yamani LN, Yano Y, Utsumi T, et al. Profile of mutations in the reverse transcriptase and overlapping surface genes of hepatitis B virus (HBV) in treatment-naïve Indonesian HBV carriers. Jpn JInfect Dis 2017; 70: 647-55. [Crossref]
  • 65. Wu Y, Gan Y, Gao F, et al. Novel natural mutations in the hepatitis B virus reverse transcriptase domain associated with hepatocellular carcinoma. PloS one 2014; 9: e94864. [Crossref]
  • 66. Costantino A, Spada E, Equestre M, et al. Naturally occurring mutations associated with resistance to HCV NS5B polymerase and NS3 protease inhibitors in treatment naïve patients with chronic hepatitis C. Virol J 2015; 12: 186. [Crossref]
  • 67. Toy M, Onder FO, Idilman R, et al. The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle-income country. Eur J Health Econ 2012; 13(5): 663-76. [Crossref]
  • 68. Toy M, Önder FO, Wörmann T, et al. Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review. BMC Infect Dis 2011; 11: 337. [Crossref]
APA Husseini A, SAEED K, Yurdcu E, BOZDAYI A (2020). Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. , 658 - 666. 10.5152/tjg.2020.19169
Chicago Husseini Abbas Ali,SAEED Khwaja Mir Islam,Yurdcu Esra,BOZDAYI A. Mithat Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. (2020): 658 - 666. 10.5152/tjg.2020.19169
MLA Husseini Abbas Ali,SAEED Khwaja Mir Islam,Yurdcu Esra,BOZDAYI A. Mithat Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. , 2020, ss.658 - 666. 10.5152/tjg.2020.19169
AMA Husseini A,SAEED K,Yurdcu E,BOZDAYI A Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. . 2020; 658 - 666. 10.5152/tjg.2020.19169
Vancouver Husseini A,SAEED K,Yurdcu E,BOZDAYI A Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. . 2020; 658 - 666. 10.5152/tjg.2020.19169
IEEE Husseini A,SAEED K,Yurdcu E,BOZDAYI A "Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan." , ss.658 - 666, 2020. 10.5152/tjg.2020.19169
ISNAD Husseini, Abbas Ali vd. "Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan". (2020), 658-666. https://doi.org/10.5152/tjg.2020.19169
APA Husseini A, SAEED K, Yurdcu E, BOZDAYI A (2020). Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. Turkish Journal of Gastroenterology, 31(9), 658 - 666. 10.5152/tjg.2020.19169
Chicago Husseini Abbas Ali,SAEED Khwaja Mir Islam,Yurdcu Esra,BOZDAYI A. Mithat Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. Turkish Journal of Gastroenterology 31, no.9 (2020): 658 - 666. 10.5152/tjg.2020.19169
MLA Husseini Abbas Ali,SAEED Khwaja Mir Islam,Yurdcu Esra,BOZDAYI A. Mithat Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. Turkish Journal of Gastroenterology, vol.31, no.9, 2020, ss.658 - 666. 10.5152/tjg.2020.19169
AMA Husseini A,SAEED K,Yurdcu E,BOZDAYI A Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. Turkish Journal of Gastroenterology. 2020; 31(9): 658 - 666. 10.5152/tjg.2020.19169
Vancouver Husseini A,SAEED K,Yurdcu E,BOZDAYI A Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. Turkish Journal of Gastroenterology. 2020; 31(9): 658 - 666. 10.5152/tjg.2020.19169
IEEE Husseini A,SAEED K,Yurdcu E,BOZDAYI A "Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan." Turkish Journal of Gastroenterology, 31, ss.658 - 666, 2020. 10.5152/tjg.2020.19169
ISNAD Husseini, Abbas Ali vd. "Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan". Turkish Journal of Gastroenterology 31/9 (2020), 658-666. https://doi.org/10.5152/tjg.2020.19169